BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38310994)

  • 1. METTL3/16-mediated m
    Wei H; Li W; Yang M; Fang Q; Nian J; Huang Y; Wei Q; Huang Z; Liu G; Xu Z; Hu A; Pu J
    Clin Immunol; 2024 Apr; 261():109924. PubMed ID: 38310994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 and METTL14-mediated N
    Wu X; Zeng M; Wei Y; Lu R; Huang Z; Huang L; Huang Y; Lu Y; Li W; Wei H; Pu J
    Sci Rep; 2024 Mar; 14(1):6155. PubMed ID: 38486042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
    Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
    Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
    Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
    Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.
    Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z
    Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages.
    Pu J; Li W; Wang A; Zhang Y; Qin Z; Xu Z; Wang J; Lu Y; Tang Q; Wei H
    Cell Death Dis; 2021 Nov; 12(12):1103. PubMed ID: 34815380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
    Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
    Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
    Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
    J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
    Yang J; Xing Z
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
    Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
    Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
    Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma.
    Wei R; Zhu WW; Yu GY; Wang X; Gao C; Zhou X; Lin ZF; Shao WQ; Wang SH; Lu M; Qin LX
    Int J Cancer; 2021 Mar; 148(5):1233-1244. PubMed ID: 33205453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 m
    Ke W; Zhang L; Zhao X; Lu Z
    Apoptosis; 2022 Jun; 27(5-6):426-440. PubMed ID: 35503144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.